Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $26.11, with a market capitalization of 148.78B. The stock trades at a price-to-earnings (P/E) ratio of 20.04 and offers a dividend yield of 6.6%.
On 2026-05-29, Pfizer(PFE) stock traded between a low of $25.93 and a high of $26.22. Shares are currently priced at $26.11, which is +0.7% above the low and -0.4% below the high.
The Pfizer(PFE)'s current trading volume is 14.28M, compared to an average daily volume of 30.82M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $23.06.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $23.06.
PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Pfizer (PFE) announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating Lorbrena versus Xalkori in people with previously untr...
Analyst ratings
55%
of 29 ratingsMore PFE News
The agreement comprises an upfront payment of $650 million to Innovent, with potential development, regulatory, and commercial milestone payments reaching up to...
Pfizer (PFE) and Innovent Biologics (IVBIY) (IVBXF) have entered into a global oncology partnership worth up to $10.5B, underscoring growing demand among multin...
In May 2026, Sarah Cannon Research Institute announced a collaboration with Pfizer to accelerate development of Pfizer’s oncology portfolio using SCRI’s Acceler...
Pfizer (PFE) and Innovent Biologics (IVBXF) announced the companies have entered into a strategic global licensing and collaboration agreement for the research...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
UBS analyst Michael Yee has maintained their neutral stance on PFE stock, giving a Hold rating today. Unlock trusted, data-backed investing tools with TipRanks...
Pfizer (PFE) has put fresh clinical and regulatory news in focus, including new European approval for hemophilia treatment HYMPAVZI, promising pneumococcal vacc...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.